Work

Proteomic analysis identifies circulating proteins associated with plasma amyloid βeta and incident dementia

Year: 2022
Type: article
Abstract: Background \nPlasma amyloid beta (Aβ42, Aβ40, and Aβ42/Aβ40), biomarkers of the Alzheimer’s form of dementia, are under consideration for clinical use. The associations of these peptides with circulating proteins may identify novel plasma biomarkers of dementia and inform peripheral factors influencing the levels of these peptides. \n \nMethods \nWe analyzed the association of these three plasma Aβ measures with 4,638 circulating proteins among a subset of the participants of the Atherosclerosis Risk in Communities (ARIC) study (midlife: n=1,955; late-life: n=2,082), related the Aβ-associated proteins with incident dementia in the overall ARIC cohort (midlife: n=11,069, late-life: n=4,110) with external replication in the Age, Gene/Environment Susceptibility (AGES) - Reykjavik Study (n=4,973), estimated the proportion of Aβ variance explained, and conducted enrichment analyses to characterize the proteins associated with the plasma Aβ peptides. \n \nResults \nAt midlife, of the 296 Aβ-associated proteins, 8 were associated with incident dementia from midlife and late-life in ARIC, and NPPB, IBSP, and THBS2 were replicated in AGES. At late-life, of the 34 Aβ-associated proteins, none were associated with incident dementia at midlife, and kidney function explained 10%, 12%, 0.2% of the variance of Aβ42, Aβ40, and Aβ42/Aβ40, respectively. Aβ42-associated proteins at midlife were found to be enriched in the liver and those at late-life were found to be enriched in the spleen. \n \nConclusions \nThis study identifies circulating proteins associated with plasma Aβ levels and incident dementia and informs peripheral factors associated with plasma Aβ levels.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7070799983
FWCI:
Cites:
Cited by:
Related to: 10